← All companies
SILO
Silo Pharma, Inc.
$4.60
+0.28 +6.48%
Key statistics
from XBRL data in SEC filingsMarket cap
$74.8M
Revenue (TTM)
$72.1K
Net income (TTM)
-$4.84M
EPS (TTM)
$-0.39
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$3.90M
Total assets
$7.02M
Gross margin
11.9%
52-week range
$3.32 – $15.15
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jul 13, 2026
8-K
Other events
Jun 18, 2026
8-K
Modified rights of security holders; Amended charter or bylaws; Other events
Jun 3, 2026
8-K
Other events
Jun 1, 2026
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Entered a material agreement; Unregistered sale of equity
Apr 2, 2026
10-K
Fiscal year ended 2025-12-31
Mar 27, 2026
8-K
Unregistered sale of equity; Other events
Feb 23, 2026
8-K
Delisting notice or listing-rule failure
Dec 29, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Director or officer change; Shareholder vote results
Oct 24, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Oct 1, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Other events
Aug 5, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jul 29, 2025
8-K
Entered a material agreement
Jul 10, 2025
8-K
Delisting notice or listing-rule failure
Jul 3, 2025
8-K
Entered a material agreement; Other events
May 16, 2025
10-Q
Quarter ended 2025-03-31
May 9, 2025
10-K
Fiscal year ended 2024-12-31
Mar 28, 2025
8-K
Regulation FD disclosure; Other events
Mar 10, 2025
8-K
Other events
Mar 7, 2025
8-K
Other events
Jan 2, 2025
8-K
Shareholder vote results
Dec 20, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Other events
Nov 8, 2024
8-K
Regulation FD disclosure; Other events
Sep 10, 2024
10-Q
Quarter ended 2024-06-30
Aug 13, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jul 22, 2024
8-K
Entered a material agreement; Other events
Jul 8, 2024
8-K
Entered a material agreement
Jun 27, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Jun 6, 2024
8-K
Other events
Jun 4, 2024
10-Q
Quarter ended 2024-03-31
May 13, 2024
8-K
Other events
Apr 5, 2024
10-K
Fiscal year ended 2023-12-31
Mar 25, 2024
8-K
Other events
Feb 1, 2024
8-K/A
Other events
Jan 11, 2024
8-K
Other events
Jan 9, 2024
8-K
Shareholder vote results
Dec 11, 2023